Skip to main content

Volume 2 Supplement 1

ESICM LIVES 2014

0714. Interaction between adipokines and the metabolic stress response: angpt l2 cxcl5 and visfatin in patients undergoing cardiac surgery

Introduction

Adipose tissue plays an intriguing role in the endocrine system by producing adipokines [1]. In patients with obesity, metabolic syndrome, and type 2 diabetes (DM2), insulin resistance is influenced by adipokines [1].

From a metabolic point of view, the stress response caused by surgical injury imitates the diabetic state. Stereotypical endocrine-metabolic and inflammatory reactions result in catabolism and pronounced insulin resistance, which is related to outcome [2].

Objectives

Three adipokines including angiopoietin-like protein 2 (ANGPTL2), CXC-chemokine ligand 5 (CXCL5), and Visfatin that are known to interact with insulin resistance [1] were evaluated in patients undergoing cardiac surgery.

Methods

Sixty-six patients scheduled for elective aortocoronary bypass surgery and/or valve repair were consecutively enrolled receiving standardized perioperative care. Serum adipokine concentrations were assessed before anesthesia induction as baseline values, upon arrival on the intensive care unit, on the first (POD1) and third (POD3) day postoperatively.

Results

Patients' baseline characteristics are shown in table 1. ANGPTL2 increased from baseline until POD1 and remained elevated on POD3 (table 2). In contrast, CXCL5 levels decreased during surgery and returned to baseline by POD3. Visfatin levels increased during surgery, showed a decrease by POD1 only to increase again by POD3. DM2 patients appear to exhibit a marked Visfatin increase during surgery, as well as a pronounced increase in CXCL5 from POD1 to POD3.

Table 1
Table 2

Conclusions

This exploratory study assessed for the first time the perioperative levels of ANGPTL2, CXCL5, and Visfatin. Further studies are warranted to correlate adipokine concentrations with insulin resistance and surgical outcomes and to investigate the potential role of adipokines as biomarkers or therapeutic targets.

References

  1. 1.

    Ouchi N, et al.: Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11: 85–97. 10.1038/nri2921

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  2. 2.

    Coursin DB, et al.: Perioperative diabetic and hyperglycemic management issues. Crit Care Med 2004, 32: S116–25. 10.1097/01.CCM.0000115623.52021.C0

    PubMed  Article  Google Scholar 

Download references

Grant acknowledgment

Research Fond, Department of Anesthesia and Surgical Intensive Care, University Hospital Basel, Switzerland.

Author information

Affiliations

Authors

Corresponding author

Correspondence to A Kopp Lugli.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Meyer, T., Nitschmann, E., Schurr, U. et al. 0714. Interaction between adipokines and the metabolic stress response: angpt l2 cxcl5 and visfatin in patients undergoing cardiac surgery. ICMx 2, P46 (2014). https://doi.org/10.1186/2197-425X-2-S1-P46

Download citation

Keywords

  • Insulin Resistance
  • Metabolic Stress
  • Anesthesia Induction
  • CXCL5 Level
  • Aortocoronary Bypass